Clinical trial
Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer
NCT00004206 · University of Leicester, Other · Unknown status
Key facts
| NCT number | NCT00004206 |
|---|---|
| Title | Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer |
| Official title | Phase II Study of Oxaliplatin and 5 Fluorouracil in the Treatment of Advanced Ovarian Cancer |
| Lead sponsor | University of Leicester, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Drug |
| Interventions | FOLFOX regimen, fluorouracil, leucovorin calcium, oxaliplatin |
| Start date | Sep 1, 1999 |
| First posted | Nov 4, 2003 |
| Last update posted | Jun 24, 2014 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: